(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.03%) $0.926
(-0.05%) $10.84
(-0.13%) $0.791
(-0.09%) $92.49
Live Chart Being Loaded With Signals
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters...
Stats | |
---|---|
Today's Volume | 11 900.00 |
Average Volume | 12 035.00 |
Market Cap | 10.57B |
EPS | ¥0 ( 2024-01-30 ) |
Next earnings date | ( ¥0 ) 2024-05-12 |
Last Dividend | ¥30.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 26.50 |
ATR14 | ¥4.58 (0.45%) |
Volume Correlation
DVx Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
DVx Inc. Correlation - Currency/Commodity
DVx Inc. Financials
Annual | 2022 |
Revenue: | ¥47.48B |
Gross Profit: | ¥5.46B (11.49 %) |
EPS: | ¥90.21 |
Q3 | 2023 |
Revenue: | ¥11.61B |
Gross Profit: | ¥1.16B (9.95 %) |
EPS: | ¥-11.41 |
Q2 | 2023 |
Revenue: | ¥11.03B |
Gross Profit: | ¥1.15B (10.47 %) |
EPS: | ¥9.72 |
Q1 | 2023 |
Revenue: | ¥11.60B |
Gross Profit: | ¥1.18B (10.15 %) |
EPS: | ¥12.68 |
Financial Reports:
No articles found.
DVx Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥5.00 | 2010-03-29 |
Last Dividend | ¥30.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | ¥229.63 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.23 | -- |
Div. Sustainability Score | 6.93 | |
Div.Growth Potential Score | 3.58 | |
Div. Directional Score | 5.26 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9069.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8218.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7611.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
6857.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6262.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4996.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% | |
4220.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3453.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2594.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
9719.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00861 | 1.500 | 9.83 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0175 | 1.200 | 9.42 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0432 | 1.500 | -0.631 | -0.947 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.617 | 0.800 | 6.92 | 5.53 | [1 - 3] |
quickRatioTTM | 1.439 | 0.800 | 6.24 | 4.99 | [0.8 - 2.5] |
cashRatioTTM | 0.563 | 1.500 | 7.98 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 3 364.07 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.107 | 1.000 | -1.548 | -1.548 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0183 | 1.000 | -1.634 | -1.634 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 2.03 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 6.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.48 | 1.000 | 7.43 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0432 | 2.50 | -0.406 | -0.947 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 7.94 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.855 | 1.500 | 0.966 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0186 | 1.000 | -2.03 | 0 | [0.1 - 0.5] |
Total Score | 3.58 |
DVx Inc.
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators